CLINICA GROUP   Report issue

For profit Phase 3
Founded: Chéraga Algeria (2007)

Organization Overview

First Clinical Trial
2015
NCT03413579
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Alternative names

CLINICA GROUP

Active Ingredients

Drugs in Phase 3 Trials (1)

nimotuzumab (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Uterine Cervical Neoplasms (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 1